Kindred Biosciences (KIN) Misses Q4 EPS by 4c

Kindred Biosciences (NASDAQ: KIN) reported Q4 EPS of ($0.35), $0.04 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08
• Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c